Pharmaceutical Raw Anti-Cancer API Cabazitaxel ntụ ntụ CAS 183133-96-2

Ozi ngwaahịa

Aha:Cabazitaxel

Nọmba CAS:183133-96-2

Usoro kemịkalụ:C45H57NO14

Nkọwapụta:99%

Agba:ọcha ma ọ bụ na-acha ọcha ntụ ntụ

Isi mmalite:Semi-synthesized na 10-DAB

Ụdị:API

Ọrụ

Nnwale ụlọ ọgwụ egosila na cabazitaxel nwere ike ibelata etuto ahụ, belata uto ma ọ bụ mgbasa nke etuto ahụ, ma belata ihe mgbaàmà nke ọrịa kansa prostate.

Hande mmepụta ike

Usoro mmepụta:30-45 ụbọchị.

Ogbe mmepụta:Otu ogbe nwere ike iwepụta ihe dị ka kilogram 15.

Ike mmepụta Hande:enwere ngwaahịa na enwere ike imepụta ọtụtụ.

Hande mmepụta uru

Hande, nke wuru ya GMP mmepụta isi, gafere nyochaa nke iwu na ụkpụrụ nke FDA, EDQM, GMP na China, PMDA na Japan, TGA na Australia, South Korea, India, Taiwan, China, Turkey, Russia, SGS , Dun & Bradley, etc.N'otu oge ahụ, ụlọ ọrụ na-onwem na nnyocha na mmepe otu na-aga nke ọma nwetara a ọnụ ọgụgụ nke patents.QC ule ụlọ, ukwuu n'aghọta ngwaahịa oru ngo ule.

Ọrụ anyị

1.Ngwaahịa:Nye elu-edu, elu-ọcha osisi wepụ, ọgwụ akụrụngwa, na ọgwụ intermediates.

2.Ọrụ nka:Mwepụta ahaziri iche nwere nkọwa pụrụ iche dị ka ihe ndị ahịa chọrọ.